Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-25-027323
Filing Date
2025-02-14
Accepted
2025-02-14 16:34:06
Documents
17
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d813039d10qa.htm   iXBRL 10-Q/A 54235
2 EX-31.1 d813039dex311.htm EX-31.1 3617
3 EX-31.2 d813039dex312.htm EX-31.2 3617
  Complete submission text file 0001193125-25-027323.txt   392937

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cnta-20240930.xsd EX-101.SCH 6066
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnta-20240930_def.xml EX-101.DEF 18835
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnta-20240930_lab.xml EX-101.LAB 24877
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnta-20240930_pre.xml EX-101.PRE 20181
19 EXTRACTED XBRL INSTANCE DOCUMENT d813039d10qa_htm.xml XML 21558
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40445 | Film No.: 25629860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)